Healthy Skepticism Library item: 7701
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Morgan SG, McMahon M, Mitton C, Roughead E, Kirk R, Kanavos P, Menon D.
Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom.
Health Aff (Millwood) 2006 Mar-Apr; 25:(2):337-47
http://content.healthaffairs.org/cgi/content/full/25/2/337
Abstract:
Many countries have centralized the clinical and economic assessments necessary for evidence-based drug coverage policy. We analyze such processes in Australia, Canada, New Zealand, and the United Kingdom. These countries apply comparable approaches to the assessment and appraisal of evidence but apply the processes to different types of drugs and use the reviews within different decision-making contexts. Review processes applied to all medicines and clearly tied to coverage decisions appear to influence national drug use. Rigor of process and transparency of data and rationale are believed to be important for maximizing the impact and political acceptability of the processes.
Keywords:
Publication Types:
Comparative Study
Research Support, Non-U.S. Gov't
MeSH Terms:
Australia
Canada
Decision Making, Organizational
Drug Approval/economics
Drug Approval/organization & administration*
Economics, Pharmaceutical
Evidence-Based Medicine
Formularies*
Government Agencies*
Great Britain
Health Policy
Humans
Insurance Coverage*
Insurance, Pharmaceutical Services*
New Zealand
Time Factors
United States
